Achillion Pharmaceuticals (ACHN)
Create an Alert
8.13
+0.12 +1.50%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Achillion Pharmaceuticals Return on Assets:
-47.81% for March 31, 2013Achillion Pharmaceuticals Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -47.81% |
| Dec. 31, 2012 | -59.38% |
| Sept. 30, 2012 | -59.10% |
| June 30, 2012 | -52.19% |
| March 31, 2012 | -53.65% |
| Dec. 31, 2011 | -57.11% |
| Sept. 30, 2011 | -51.53% |
| June 30, 2011 | -58.51% |
| March 31, 2011 | -67.53% |
| Dec. 31, 2010 | -69.36% |
| Sept. 30, 2010 | -90.89% |
| June 30, 2010 | -124.2% |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
ACHN Return on Assets Benchmarks
| Companies | |
|---|---|
| Transcept Pharmaceuticals | -19.12% |
| Merrimack Pharmaceuticals | -81.40% |
| Vertex Pharmaceuticals | -19.76% |
ACHN Return on Assets Rankings
| Overall |
58th percentile 6975 of 16782 |
| Sector |
60th percentile 560 of 1410 in Healthcare |
| Industry |
67th percentile 148 of 454 in Biotechnology |
ACHN Return on Assets Range, Past 5 Years
| Minimum | -124.2% | Jun 2010 |
| Maximum | -47.81% | Mar 2013 |
| Average | -74.35% |
